Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | March 09, 2023 09:06am

Gainers

  • Neoleukin Therapeutics (NASDAQ:NLTX) stock moved upwards by 32.4% to $0.7 during Thursday's pre-market session. The company's market cap stands at $29.9 million.
  • Biophytis (NASDAQ:BPTS) shares increased by 28.02% to $0.64. The market value of their outstanding shares is at $13.0 million.
  • First Wave BioPharma (NASDAQ:FWBI) shares increased by 26.75% to $4.5. The company's market cap stands at $4.4 million.
  • Macrogenics (NASDAQ:MGNX) shares moved upwards by 18.18% to $6.5. The company's market cap stands at $399.5 million.
  • Avenue Therapeutics (NASDAQ:ATXI) stock rose 16.34% to $1.21. The market value of their outstanding shares is at $6.6 million.
  • Ampio Pharmaceuticals (AMEX:AMPE) stock moved upwards by 11.93% to $0.34. The market value of their outstanding shares is at $5.0 million.

Losers

  • OptimizeRx (NASDAQ:OPRX) stock decreased by 18.4% to $13.25 during Thursday's pre-market session. The company's market cap stands at $227.2 million. The company's, Q4 earnings came out yesterday.
  • Landos Biopharma (NASDAQ:LABP) shares decreased by 13.14% to $0.33. The market value of their outstanding shares is at $13.2 million.
  • Akebia Therapeutics (NASDAQ:AKBA) shares decreased by 11.66% to $0.91. The company's market cap stands at $167.6 million. As per the press release, Q4 earnings came out today.
  • Fulcrum Therapeutics (NASDAQ:FULC) shares decreased by 10.39% to $5.61. The company's market cap stands at $345.9 million. As per the press release, Q4 earnings came out today.
  • Ontrak (NASDAQ:OTRKP) stock decreased by 9.2% to $0.79.
  • Novo Integrated Sciences (NASDAQ:NVOS) shares fell 8.08% to $0.18. The company's market cap stands at $24.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKBA AMPE ATXI BPTS FULC FWBI LABP MGNX NLTX NVOS OPRX OTRKP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist